---

Proceedings of the Standing Senate Committee on
Banking, Trade and Commerce

Issue 4 - Minutes of Proceedings

---

OTTAWA, Wednesday, March 21, 2001
(5)

[English]

The Standing Committee on Banking, Trade and Commerce met at 3:45 p.m. this day, in Room 505, Victoria Building, the Chairman, the Honourable Senator Kolber, presiding.

Members of the committee present: The Honourable Senators Angus, Di Nino, Furey, Gustafson, Hervieux-Payette, P.C., Kelleher, P.C., Kolber, Kroft, Lynch-Staunton, Poulin, Setlakwe, Taylor, Tkachuk and Wiebe (14).

Other senators present: The Honourable Senators Lawson, St Germain, P.C., and Tunney (3).

In attendance: Mr. Stephen L. Harris, and from the Parliamentary Research Branch, Library of Parliament, Law and Government Division: Mr. Geoff Kieley, Research Officer.

Also in attendance: The official reporters of the Senate.

APPEARING

The Honourable Brian Tobin, P.C., M.P., Minister of Industry.

WITNESSES:

From Industry Canada:

Andrei Sulzenko, Assistant Deputy Minister;

Susan Bincoletto, Director, Special Projects;

Rob Sutherland-Brown, Senior Counsel,

From Canada's Research-Based Pharmaceutical Companies:

Murray J. Elston, President of Rx&D;

Dr. Aldo Baumgartner, Chairman & CEO of Wyeth-Ayerst Canada Inc. and Chairman of the Board of Directors of Rx&D;

Bernadette Connaughton, President & General Manager of Bristol-Myers Squibb Pharmaceutical Group;

Dan Wayand, General Manager of Procter & Gamble Pharmaceuticals Canada Inc.;

Terry McCool, Vice President of Corporate Affairs of Eli Lilly Canada Inc.

Pursuant to the Order of Reference adopted by the Senate on Monday, March 12, 2001, the committee began its examination of Bill S-17, An Act to amend the Patent Act.

The Honourable Brian Tobin made a statement and with the witnesses from Industry Canada answered questions.

Messrs Elston, Baumgartner and McCool made a statement and with the other witnesses from Canada's Research-Based Pharma ceutical Companies answered questions.

Pursuant to the Order of Reference adopted by the Senate on Thursday, March 1, 2001, the committee continued its examination of Bill S-16, An Act to amend the Proceeds of Crime (Money Laundering) Act.

After debate,

It was agreed, - That clause-by-clause consideration of Bill S-16 proceed.

It was agreed - That the title be stood.

It was agreed - That clause 1 carry on division.

It was agreed - That clause 2 carry on division.

It was agreed - That clause 3 carry on division.

It was agreed - That clause 4 carry on division.

It was agreed, - That the Title carry on division.

It was agreed, - That Bill S-16 carry on division.

It was agreed, - That Bill S-16 be reported to the Senate without amendment.

At 6:10 p.m., the committee adjourned to the call of the Chair.

ATTEST:

Denis Robert

Clerk of the Committee

---